Primary record
5-[[3-[3,5-bis[[2,3-dihydroxy-1-(hydroxymethyl)propyl]carbamoyl]-2,4,6-triiodo-N-methyl-anilino]-3-oxo-propanoyl]-methyl-amino]-N1,N3-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodo-benzene-1,3-dicarboxamide
- 库存
- 9,557 克
- 纯度
- 99.7 %
- CAS
- 79770-24-4
化合物标识与属性
- CAS
- 79770-24-4
- PubChem CID
- 3738
- SMILES
- CN(C1=C(C(=C(C(=C1I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I)C(=O)CC(=O)N(C)C2=C(C(=C(C(=C2I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I
- Canonical SMILES
- CN(C(=O)CC(=O)N(C)c1c(I)c(C(=O)NC(CO)C(O)CO)c(I)c(C(=O)NC(CO)C(O)CO)c1I)c1c(I)c(C(=O)NC(CO)C(O)CO)c(I)c(C(=O)NC(CO)C(O)CO)c1I
名称与同义词
- iotrolan
- Iotrol
- Isovist
- Iotrovist
- Osmovist
- Iotrolanum
- Iotrolum
- Osmovist 190
- Osmovist 240
- Dasatinib
- Isovist 300
- Iotrolanum [Latin]
- Iotrolan CRS
- Iotrolan(isovist)
- Iotrolum [INN-Latin]
- 79770-24-4
- Isovist 240
- Compound ZK 39482
- IOTROLAN [USAN]
- RefChem:57665
- IOTROLAN [INN]
- IOTROLAN [JAN]
- IOTROLAN [MI]
- AC1L1GLN
- AC1Q3VSR
- AC1Q4PLO
- Compound ZK-39482
- IOTROLAN [VANDF]
- Isovist 300 (TN)
- IOTROLAN [MART.]
- D0B8LN
- IOTROLAN [WHO-DD]
- DL-3117
- SCHEMBL25535
- DTXSID0023165
- Iotrolan (JAN/USAN/INN)
- UNII-16FL47B687
- SHL-437AA
- Iotrolan [USAN:BAN:INN:JAN]
- Iotrolan [USAN:INN:BAN:JAN]
- IOTROLAN [ORANGE BOOK]
- Iotrolan for system suitability
- SH 437
- DTXCID303165
- C37H48I6N6O18
- IOTROLAN [EP MONOGRAPH]
- 16FL47B687
- CHEMBL1200555
- DL 3-117
- CHEBI:31715
- SH-L-437D
- CID3738
- V08AB06
- ZK 39 482
- ZK 39482
- ZK-39482
- CID:3738
- DL 3117
- Iotrolan for system suitability CRS
- ZK-39-482
- AR-1G5853
- EBC-27574
- DL-3-117
- DB09487
- C37-H48-I6-N6-O18
- AN-36499
- DA-54358
- I663
- J24.140G
- LS-29736
- SID:134222897
- HY-107992
- CS-0031118
- FT-0754152
- NS00005779
- D01714
- 1,3-Benzenedicarboxamide, 5,5'-((1,3-dioxo-1,3-propanediyl)bis(methylimino))bis(N,N'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodo-
- 2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-N-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
- 770I244
- C033300
- EN300-19767814
- Q6064149
- 5,5'-(Malonylbis(methylimino))bis(N,N'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl)-2,4,6-triiodoisophthalamide)
- 1,3-Benzenedicarboxamide, 5,5'-((1,3-dioxo-1,3-propanediyl)bis(methylimino))bis(N,N'-bis(2,3-dihydroxy-1-(hydroxymethyl)propyl))-2,4,6-triiodo-
- 2,4,6-triiodo-5-{N-methyl-2-[methyl({2,4,6-triiodo-3,5-bis[(1,3,4-trihydroxybutan-2-yl)carbamoyl]phenyl})carbamoyl]acetamido}-N1,N3-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
- 5,5'-[malonylbis(methylimino)]bis[n,n'-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodoisophthalamide]
- Iotrol; Iotrolan; Iotrovist; Isovist; Isovist 240; Isovist 280; Isovist 300; SHL 437AA; ZK 39482
- 2,4,6-triiodo-5-(N-methyl-2-(methyl((2,4,6-triiodo-3,5-bis((1,3,4-trihydroxybutan-2-yl)carbamoyl)phenyl))carbamoyl)acetamido)-N1,N3-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
- 2,4,6-triiodo-5-[methyl-[3-[methyl-[2,4,6-triiodo-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)phenyl]amino]-3-oxopropanoyl]amino]-N,N'-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide
- 5,5 -[(1,3-Dioxo-1,3-propanediyl)bis(methylimino)]bis[N,N -bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodo-1,3-benzenedicarboxamide]
- 5,5'-(malonylbis(methylazanediyl))bis(2,4,6-triiodo-N1,N3-bis(1,3,4-trihydroxybutan-2-yl)isophthalamide)
- 5,5'-[(1,3-Dioxopropane-1,3-diyl)bis(methylazanediyl)]bis[2,4,6-triiodo-N~1~,N~3~-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide]
- 5,5'-[(1,3-dioxopropane-1,3-diyl)bis(methylimino)]bis{N,N'-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodobenzene-1,3-dicarboxamide}
- 5-[[3-[3,5-bis[[2,3-dihydroxy-1-(hydroxymethyl)propyl]carbamoyl]-2,4,6-triiodo-N-methyl-anilino]-3-oxo-propanoyl]-methyl-amino]-N1,N3-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-2,4,6-triiodo-benzene-1,3-dicarboxamide
- 83922-23-0
- N,N -Dimethyl-N,N -bis[3,5-bis[[1-(hydroxymethyl)-2,3-dihydroxypropyl]carbamoyl]-2,4,6-triiodophenyl]malonamide